VanEck Biotech ETF (BBH)
Every component of BBH and its weight in the fund, as of 2026-10-19.
| Component | Weight | % | Sector |
|---|---|---|---|
| AMGNAmgen Inc · United States | 15.76% | Healthcare | |
| GILDGilead Sciences Inc · United States | 14.67% | Healthcare | |
| VRTXVertex Pharmaceuticals Inc · United States | 7.94% | Healthcare | |
| MRNAModerna Inc · United States | 7.28% | Healthcare | |
| REGNRegeneron Pharmaceuticals Inc · United States | 6.63% | Healthcare | |
| NTRANatera Inc · United States | 4.69% | Healthcare | |
| IQVIQVIA Holdings Inc · United States | 4.42% | Healthcare | |
| ARGXargenx NV ADR · United States | 4.12% | Healthcare | |
| ILMNIllumina Inc · United States | 4.05% | Healthcare | |
| RVMDRevolution Medicines Inc · United States | 3.59% | Healthcare | |
| BIIBBiogen Inc · United States | 2.89% | Healthcare | |
| BGNEBeiGene Ltd · United States | 2.85% | Healthcare | |
| ALNYAlnylam Pharmaceuticals Inc · United States | 2.70% | Healthcare | |
| GHGuardant Health Inc · United States | 2.60% | Healthcare | |
| INCYIncyte Corporation · United States | 2.20% | Healthcare | |
| UTHRUnited Therapeutics Corporation · United States | 2.20% | Healthcare | |
| INSMInsmed Inc · United States | 1.88% | Healthcare | |
| CRLCharles River Laboratories · United States | 1.51% | Healthcare | |
| BNTXBioNTech SE · United States | 1.46% | Healthcare | |
| NBIXNeurocrine Biosciences Inc · United States | 1.41% | Healthcare | |
| ICLRICON PLC · United States | 1.22% | Healthcare | |
| TECHBio-Techne Corp · United States | 1.16% | Healthcare | |
| QGENQiagen NV · United States | 0.99% | Healthcare | |
| BMRNBiomarin Pharmaceutical Inc · United States | 0.99% | Healthcare | |
| TEMTempus AI, Inc. Class A Common Stock · United States | 0.90% | Healthcare |
From the market data provider's fund data, read 2026-10-19. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.